SON-DP

DRUG2 trials

Sponsors

Qurgen Inc.

Conditions

Breast CancerColorectal CancerGastric CancerLiver CancerOvarian CancerPancreatic CancerSolid Tumor

Phase 1

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

RecruitingNCT05989724

Qurgen Inc.Breast Cancer, Colorectal Cancer, Ovarian Cancer +2

Start: 2023-09-19End: 2026-03-31Target: 150Updated: 2024-04-24

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

RecruitingNCT06873659

Qurgen Inc.Gastric Cancer, Liver Cancer, Solid Tumor

Start: 2025-02-26End: 2027-11-30Target: 96Updated: 2025-09-03